You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Dow
McKinsey
McKesson

Last Updated: September 24, 2023

Investigational Drug Information for Putrescine


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Putrescine?

Putrescine is an investigational drug.

There have been 7 clinical trials for Putrescine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Hypersensitivity, and Colorectal Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Associazione Oncologia Traslazionale, and Thomas E. Ahlering.

There are one hundred and thirty-two US patents protecting this investigational drug and twenty-seven international patents.

Recent Clinical Trials for Putrescine
TitleSponsorPhase
Effect of Probiotic Lozenges on Halitosis in Patients With Chronic PeriodontitisBioGaia ABPhase 4
Effect of Probiotic Lozenges on Halitosis in Patients With Chronic PeriodontitisUniversity of ZagrebPhase 4
Feasibility Study on Stem Cells Sensitivity AssayAssociazione Oncologia TraslazionalePhase 2

See all Putrescine clinical trials

Clinical Trial Summary for Putrescine

Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine

See all Putrescine clinical trials

US Patents for Putrescine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Putrescine ⤷  Try a Trial Acylated amine compounds which are useful fungicigal agents Roussel Uclaf (Paris, FR) ⤷  Try a Trial
Putrescine ⤷  Try a Trial Liquid developer for electrostatic photography Fuji Photo Film Co., Ltd. (Kanagawa, JP) ⤷  Try a Trial
Putrescine ⤷  Try a Trial Method for quantitative determination of polyamines Tokuyama Soda Co., Ltd. (Tokuyama, JP) ⤷  Try a Trial
Putrescine ⤷  Try a Trial Process for producing unsaturated mono and dicarboxylic acid imide compound Matsushita Electric Works Ltd. (Osaka, JP) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Putrescine

Drugname Country Document Number Estimated Expiration Related US Patent
Putrescine European Patent Office EP0325258 2008-01-20 ⤷  Try a Trial
Putrescine Japan JPH01185667 2008-01-20 ⤷  Try a Trial
Putrescine Germany DE69016062 2009-03-06 ⤷  Try a Trial
Putrescine European Patent Office EP0386544 2009-03-06 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Dow
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.